Owens & Minor
Market Cap
US$455.2m
Last Updated
2019/10/21 23:39 UTC
Data Sources
Company Financials +
Executive Summary
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally.
Snowflake
Fundamentals
Slightly overvalued with imperfect balance sheet.
Similar Companies
Share Price & News
How has Owens & Minor's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
16.2%
OMI
7.0%
US Healthcare
1.0%
US Market
1 Year Return
-50.7%
OMI
-8.8%
US Healthcare
8.0%
US Market
Return vs Industry: OMI underperformed the US Healthcare industry which returned -8.8% over the past year.
Return vs Market: OMI underperformed the US Market which returned 8% over the past year.
Shareholder returns
| OMI | Industry | Market | |
|---|---|---|---|
| 7 Day | 16.2% | 7.0% | 1.0% |
| 30 Day | 28.9% | 1.8% | -0.07% |
| 90 Day | 186.9% | -2.7% | -1.0% |
| 1 Year | -50.0%-50.7% | -7.3%-8.8% | 10.4%8.0% |
| 3 Year | -75.8%-78.2% | 33.7%27.7% | 46.2%36.7% |
| 5 Year | -74.8%-78.6% | 59.4%48.8% | 64.3%46.2% |
Price Volatility Vs. Market
How volatile is Owens & Minor's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Is Owens & Minor, Inc. (NYSE:OMI) A Volatile Stock?1 month ago | Simply Wall St
Is There An Opportunity With Owens & Minor, Inc.'s (NYSE:OMI) 33% Undervaluation?1 month ago | Simply Wall St
Is Owens & Minor (NYSE:OMI) Using Too Much Debt?Valuation
Is Owens & Minor undervalued compared to its fair value and its price relative to the market?
21.4%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OMI ($7.23) is trading below our estimate of fair value ($9.2)
Significantly Below Fair Value: OMI is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: OMI is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.
PE vs Market: OMI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate OMI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: OMI is good value based on its PB Ratio (0.9x) compared to the US Healthcare industry average (2.5x).
Next Steps
Future Growth
How is Owens & Minor forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
117.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OMI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OMI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OMI's revenue (0.4% per year) is forecast to grow slower than the US market (7.2% per year).
High Growth Revenue: OMI's revenue (0.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMI's Return on Equity is forecast to be low in 3 years time (8.8%).
Next Steps
Past Performance
How has Owens & Minor performed over the past 5 years?
-60.0%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: OMI is unprofitable, and losses have increased over the past 5 years at a rate of -60% per year.
Accelerating Growth: Unable to compare OMI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OMI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (5.6%).
Return on Equity
High ROE: OMI has a negative Return on Equity (-57.75%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: OMI is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: OMI is currently unprofitable, so its Return on Capital Employed is negative.
Next Steps
Financial Health
How is Owens & Minor's financial position?
Financial Position Analysis
Short Term Liabilities: OMI's short term assets ($2.5B) exceeds its short term liabilities ($1.5B)
Long Term Liabilities: OMI's short term assets (2.5B) exceeds its long term liabilities (1.9B)
Debt to Equity History and Analysis
Debt Level: OMI's debt to equity ratio (338.2%) is considered high
Reducing Debt: OMI's debt to equity ratio has increased from 21.8% to 338.2% over the past 5 years.
Debt Coverage: OMI's debt is not well covered by operating cash flow (5.9%).
Interest Coverage: OMI is unprofitable, therefore interest payments are not well covered by earnings.
Balance Sheet
Inventory Level: OMI has a high level of physical assets or inventory.
Debt Coverage by Assets: OMI's debt is covered by short term assets (assets are 1.472680x debt).
Next Steps
Dividend
What is Owens & Minor's current dividend yield, its reliability and sustainability?
0.14%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: OMI's dividend (0.14%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: OMI's dividend (0.14%) is low compared to the top 25% of dividend payers in the US market (3.68%).
Stable Dividend: OMI is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: OMI is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: OMI is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OMI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Owens & Minor's salary, the management and board of directors tenure and is there insider trading?
0.8yrs
Average management tenure
CEO
Ed Pesicka (51yo)
0.6yrs
Tenure
Mr. Edward A. Pesicka, also known as Ed, has been the Chief Executive Officer, President and Director of Owens & Minor, Inc. since March 7, 2019. Mr. Pesicka served as Chief Commercial Officer of Thermo Fi ...
Management Age and Tenure
0.8yrs
Average Tenure
51yo
Average Age
Experienced Management: OMI's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Age and Tenure
1.6yrs
Average Tenure
66yo
Average Age
Experienced Board: OMI's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Chuck Graves
Director of Finance & Investor Relations
- Tenure: 0yrs
Ed Pesicka (51yo)
President
- Tenure: 0.6yrs
Jeff Jochims (51yo)
Executive Vice President of Strategy & Solutions
- Tenure: 0.5yrs
Robert Snead (42yo)
Executive VP & CFO
- Tenure: 1.3yrs
- Compensation: US$1.02m
Nick Pace (48yo)
Executive VP
- Tenure: 3.8yrs
- Compensation: US$1.75m
Mike Lowry (57yo)
Senior VP
- Tenure: 1.3yrs
- Compensation: US$310.84k
Chris Lowery (55yo)
President of Global Products
- Tenure: 0.8yrs
- Compensation: US$3.66m
Mark Zacur
Senior VP & Chief Procurement Officer
- Tenure: 0.3yrs
Joseph Pekala (48yo)
Senior VP & Chief Information Officer
- Tenure: 0.8yrs
Shana Neal (52yo)
Senior VP & Chief Human Resources Officer and Communications
- Tenure: 0yrs
Board Members
G. Minor (78yo)
Chairman Emeritus
- Tenure: 6.5yrs
- Compensation: US$366.50k
Craig Smith (67yo)
Chairman Emeritus
- Tenure: 0yrs
- Compensation: US$44.50k
Bob Sledd (66yo)
Chairman
- Tenure: 0.9yrs
- Compensation: US$2.39m
Anne Whittemore (72yo)
Lead Independent Director
- Tenure: 5.8yrs
- Compensation: US$281.00k
Eddie Moore (71yo)
Independent Director
- Tenure: 14.5yrs
- Compensation: US$248.20k
Mark McGettrick (61yo)
Independent Director
- Tenure: 1.6yrs
- Compensation: US$259.50k
Bob Henkel (65yo)
Director
- Tenure: 0yrs
Ed Pesicka (51yo)
President
- Tenure: 0.6yrs
Mark Beck (54yo)
Independent Director
- Tenure: 0.2yrs
Company Information
Owens & Minor, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Owens & Minor, Inc.
- Ticker: OMI
- Exchange: NYSE
- Founded: 1882
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$455.186m
- Shares outstanding: 62.96m
- Website: https://www.owens-minor.com
Number of Employees
Location
- Owens & Minor, Inc.
- 9120 Lockwood Boulevard
- Mechanicsville
- Virginia
- 23116
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| OMI | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Dec 1972 |
| 6OM | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Dec 1972 |
Biography
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Produ ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/21 23:39 |
| End of Day Share Price | 2019/10/21 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.